Dragomir G.
- Country
- Bulgaria
- Department
- Clinic of Gastroenterology
Research Overview
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa in Adults with Biopsy‑Confirmed F2–F3 Metabolic Dysfunction‑Associated Steatohepatitis
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa Safety and Tolerability in Adults with F2‑F3 Metabolic Dysfunction‑Associated Steatohepatitis
- Evaluation of Long-term Treatment Response Durability in Chronic Hepatitis B Patients Post-Bepirovirsen Therapy with or without Nucleos(t)ide Analogue Therapy
Data & Insights
Has run more than one trial at 91 of 137 partner sites.
Specializations
Hepatology Focus
The investigator specializes in chronic hepatitis B management and therapeutic interventions, with particular emphasis on evaluating long-term treatment outcomes.
- Viral Hepatitis Treatment
- Chronic HBV Infection
- Treatment Response Assessment
Active involvement in investigating sustained therapeutic responses in hepatitis B patients following antiviral interventions.
Treatment Durability
Focuses on long-term clinical outcomes and the sustainability of therapeutic interventions in chronic viral infections.
- Response Monitoring
- Follow-up Assessment
- Treatment Efficacy
Expertise in evaluating the persistence of treatment effects in chronic liver conditions.
Clinical Evaluation
Specializes in longitudinal assessment of therapeutic interventions for chronic viral hepatitis.
- Treatment Response Analysis
- Patient Monitoring
- Clinical Outcomes
Conducts systematic evaluation of treatment effectiveness in chronic hepatitis management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.